PCSK9 and coronary artery disorder: To identify potential lipoprotein-lipid parameters that may be biomarkers of mediating mechanisms for the association between APOC3 levels and CAD, we performed Two-Step cis-MR.16 We included the same cis-acting genetic instruments of APOC3 and PCSK9 as in the previous univariable MR.